Sort   by:  
 Page size 
UnknownCurrent State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.
Not available
S-EPMC6279258 | biostudies-literature
UnknownPTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.
Not available
S-EPMC11881745 | biostudies-literature
TranscriptomicsExpression profiling of bronchial epithelium
19 bronchial epithelial SAGE libraries were constructed and analyzed in this study. Discussed in the study: IDENTIFICATION OF NOVEL LUNG GENES IN BRONCHIAL EPITHELIUM BY SERIAL ANALYSIS OF GENE EXPRESSION Kim M. Lonergan1, Raj Chari1, Ronald J. deLeeuw1, Ashleen Shadeo1, Bryan Chi1, Ming-Sound Tsa...
ORGANISM(S): Homo sapiens 
2006-07-14 | E-GEOD-3707 | biostudies-arrayexpress
UnknownReconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.
Not available
S-EPMC9067708 | biostudies-literature
UnknownNivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial.
Not available
S-EPMC12092258 | biostudies-literature
UnknownEpigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.
Not available
S-EPMC9663866 | biostudies-literature
TranscriptomicsDNA profiling of serous ovarian and Fallopian tube carcinomas with array CGH and MLPA
Primary serous ovarian carcinoma (OVCA) and serous Fallopian tube carcinoma (FTC), both belonging to the BRCA-linked tumour spectrum, share many properties and are treated similarly. However, a detailed molecular comparison has been lacking. We hypothesized that comparative genomic studies of serous...
ORGANISM(S): Homo sapiens 
2008-07-08 | E-GEOD-12040 | biostudies-arrayexpress
UnknownNivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
Not available
S-EPMC6864847 | biostudies-literature
UnknownTargeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure.
Not available
S-EPMC10981050 | biostudies-literature
UnknownNivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.
Not available
S-EPMC12773585 | biostudies-literature
Sort   by:  
 Page size